Hanmi Pharm Co Ltd
KRX:128940

Watchlist Manager
Hanmi Pharm Co Ltd Logo
Hanmi Pharm Co Ltd
KRX:128940
Watchlist
Price: 445 500 KRW -1% Market Closed
Market Cap: 5.7T KRW

Wall Street
Price Targets

Price Targets Summary
Hanmi Pharm Co Ltd

Wall Street analysts forecast Hanmi Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hanmi Pharm Co Ltd is 480 037.5 KRW with a low forecast of 323 200 KRW and a high forecast of 588 000 KRW.

Lowest
Price Target
323 200 KRW
27% Downside
Average
Price Target
480 037.5 KRW
8% Upside
Highest
Price Target
588 000 KRW
32% Upside
Hanmi Pharm Co Ltd Competitors:
Price Targets
AXSM
Axsome Therapeutics Inc
23% Upside
AZN
AstraZeneca PLC
7% Upside
MVP
Medical Developments International Ltd
58% Upside
AMRX
Amneal Intermediate Inc
11% Upside
4523
Eisai Co Ltd
12% Upside
4530
Hisamitsu Pharmaceutical Co Inc
4% Upside

Revenue
Forecast

Revenue Estimate
Hanmi Pharm Co Ltd

For the last 13 years the compound annual growth rate for Hanmi Pharm Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 7%.

7%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hanmi Pharm Co Ltd

For the last 13 years the compound annual growth rate for Hanmi Pharm Co Ltd's operating income is 20%. The projected CAGR for the next 3 years is 14%.

20%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Hanmi Pharm Co Ltd

For the last 13 years the compound annual growth rate for Hanmi Pharm Co Ltd's net income is 42%. The projected CAGR for the next 3 years is 21%.

42%
Past Growth
21%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hanmi Pharm Co Ltd's stock price target?
Price Target
480 037.5 KRW

According to Wall Street analysts, the average 1-year price target for Hanmi Pharm Co Ltd is 480 037.5 KRW with a low forecast of 323 200 KRW and a high forecast of 588 000 KRW.

What is Hanmi Pharm Co Ltd's Revenue forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Hanmi Pharm Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 7%.

What is Hanmi Pharm Co Ltd's Operating Income forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Hanmi Pharm Co Ltd's operating income is 20%. The projected CAGR for the next 3 years is 14%.

What is Hanmi Pharm Co Ltd's Net Income forecast?
Projected CAGR
21%

For the last 13 years the compound annual growth rate for Hanmi Pharm Co Ltd's net income is 42%. The projected CAGR for the next 3 years is 21%.

Back to Top